Crohn's disease remission on bupropion

被引：42

作者：

Kane, SV ^{[1
]}

Altschuler, EL

Kast, RE

机构：

[1] Univ Chicago, Dept Med, Div Gastroenterol, Chicago, IL 60637 USA

[2] Mt Sinai Sch Med, New York, NY 10029 USA

[3] Univ Calif San Diego, Brain & Percept Lab, La Jolla, CA 92093 USA

[4] Univ Vermont, Dept Psychiat, Burlington, VT USA

来源：

关键词：

D O I：

10.1016/j.gastro.2003.02.004

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1290 / 1290

页数：1

共 6 条

[1] Catecholamines increase monocyte TNF receptors and inhibit TNF through β2-adrenoreceptor activation
Guirao, X
Kumar, A
Katz, J
Smith, M
Lin, E
Keogh, C
Calvano, SE
Lowry, SF
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (06): : E1203 - E1208
[2] Kast RE, 2001, GASTROENTEROLOGY, V121, P1260
[3] KAST RE, UNPUB INT J CARD
[4] Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: A pilot study
Modell, JG
Boyce, S
Taylor, E
Katholi, C
[J]. PSYCHOSOMATIC MEDICINE, 2002, 64 (05): : 835 - 840
[5] MECHANISMS OF DISEASE Inflammatory Bowel Disease
Abraham, Clara
Cho, Judy H.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) : 2066 - 2078
[6] MOLECULAR PHARMACOLOGY OF THE BETA-ADRENERGIC-RECEPTOR ON THP-1 CELLS
TALMADGE, J
SCOTT, R
CASTELLI, P
NEWMANTARR, T
LEE, J
[J]. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1993, 15 (02): : 219 - 228